Metabolic Cancer Therapy vs Mitochondrial Stem Cell Targeting: An Evidence-Based Comparison (2026)
Abstract Cancer research is increasingly shifting beyond purely genetic explanations toward models centered on metabolism and mitochondrial dysfunction. Two emerging frameworks are gaining attention: the metabolic therapy approach associated with Thomas Seyfried and the mitochondrial stem cell targeting strategy developed within integrative oncology. This review critically compares both approaches across biological rationale, therapeutic strategy, and available evidence. It also proposes a unified model that may better reflect the complexity of cancer biology while maintaining clinical realism and safety. 1. Introduction Despite major advances in oncology, outcomes for advanced cancers remain limited. Conventional treatments—surgery, chemotherapy, radiotherapy, and immunotherapy—primarily target tumor burden but often fail to prevent recurrence or metastasis. Two alternative but increasingly discussed frameworks attempt to address these gaps: Metabolic cancer therapy , which reframes c...